Laser trabeculoplasty is a non-surgical treatment for open-angle glaucoma that lowers ocular pressure by improving fluid drainage. Using Selective Laser Trabeculoplasty (SLT) or Argon Laser Trabeculoplasty (ALT), surgeons stimulate the trabecular meshwork to enhance the eyes natural outflow, often reducing dependency on daily medicated eye drops.
- Procedure mechanics: Laser energy triggers a biological healing response in the eyes drainage tissue.
- Selective vs. argon: Selective Laser Trabeculoplasty uses low-energy pulses to avoid permanent tissue scarring.
- Treatment timeframe: The in-office procedure typically lasts 5 to 15 minutes per eye.
- Pressure reduction: Patients often see a 20–30% drop in intraocular pressure within 1–3 months.
Bookimed Expert Insight: Thai facilities like Bumrungrad International Hospital combine JCI-accredited safety with significant value. While the procedure averages $2,500 in the US, clinics in Bangkok perform the same treatment for $900 to $1,500. This 52% saving allows patients to access US-trained specialists, such as those with fellowships from the University of Illinois or UCLA, at a fraction of the cost.
Patient Consensus: Many find the procedure a game-changer for reducing daily medications, though some notice effects may fade after 1–3 years. While most report successful pressure drops, others advise having baseline tests ready for accurate post-op monitoring.